Conquering Diseases

Daily Aspirin as a Preventative Measure Against Pancreatic Cancer

Description

This study is looking to enroll patients who are at a high risk of developing pancreatic cancer to see if taking an aspirin daily for one year can prevent or reduce the risk of developing cancer.

Overview

Patients with family members diagnosed with pancreatic cancer, certain genetic mutations or pancreatic abnormalities, like cysts, can be at a higher risk of developing pancreatic cancer. This study will compare patients taking aspirin to those that are not to see if it reduces the risk of changes in the pancreas. Patients will take aspirin for 1 year and then be followed for 4 years. Follow up visits would include blood draws and imaging tests if recommended by the study doctor.

What we're hoping for

We are hoping that taking a daily aspirin could help reduce the risk of pancreatic cancer in patients that are at high risk.

Additional Information

ClinicalTrials.gov Identifier: Not Available

 Principal Investigator

Jennifer  LaFemina, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989